Clinical Trial Update: Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial updating re-introduction of pemetrexed and cisplatin with prolonged anti-angiogenic therapy using bevacizumab in metastatic non-squamous non-small…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Non-small Cell Lung Cancer Metastatic, Nonsquamous Nonsmall Cell Neoplasm of Lung | Phase 2 | Status: COMPLETED